Cue Biopharma CUE
€ 1.02
-0.56%
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
Cue Biopharma Bilanz 2011-2024 | CUE
Bilanz Jährlich Cue Biopharma
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-40.9 M | -40.3 M | -54.3 M | -67.7 M | -38.5 M | -20.8 M | -61 M | -14.9 M | -6.41 M | - | - | - | - |
Langfristige Schulden |
4.2 M | 8.04 M | 5.12 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
3.37 M | 3.3 M | 4.93 M | 4.78 M | 4.45 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 4.31 M | 5.37 M | 5.17 M | - | 36.4 K | 34.1 K | - | - | - | - |
Kurzfristige Verbindlichkeiten |
17.1 M | 11.5 M | 12.8 M | 16.3 M | 11.7 M | 6.22 M | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
24.4 M | 25.6 M | 17.9 M | 20.6 M | 17 M | 11.4 M | 5.35 M | 1.1 M | 376 K | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | 6.68 M | 4.1 M | 2.01 M | 624 K | - | - | - | - | - | - |
Gewinnrücklagen |
-301 M | -250 M | -197 M | -153 M | -109 M | -71.8 M | -32.8 M | -9.59 M | -1.93 M | - | - | - | - |
Vermögenswerte |
61.5 M | 91.3 M | 83.4 M | 99.5 M | 71.6 M | 45.4 M | 67 M | 16.3 M | 7.31 M | - | - | - | - |
Zahlungsmittel |
48.5 M | 51.6 M | 64.4 M | 74.9 M | 44.3 M | - | - | - | - | - | - | - | - |
Buchwert |
37.1 M | 65.7 M | 65.5 M | 78.9 M | 54.6 M | 34 M | 61.6 M | 15.2 M | 6.94 M | - | - | - | - |
Gesamtes Eigenkapital |
37.1 M | 65.7 M | 65.5 M | 78.9 M | 54.6 M | 34 M | 61.6 M | 15.2 M | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Cue Biopharma
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
1.33 M | 2.29 M | 4.2 M | 5.16 M | 6.12 M | 7.08 M | 8.04 M | 8.99 M | - | 9.86 M | - | - | - | 1.08 M | 2.37 M | 2.37 M | 2.37 M | 2.37 M | 1.35 M | 1.35 M | 1.35 M | 1.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
19.4 M | 20.7 M | 24.4 M | 26.2 M | 27.2 M | 26.7 M | 25.6 M | 25.5 M | - | 26 M | 17.9 M | 15.4 M | 16.8 M | 19.1 M | 20.6 M | 20.6 M | 20.6 M | 20.6 M | 17 M | 17 M | 17 M | 17 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 5.35 M | 5.35 M | 39.2 M | 5.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-332 M | -324 M | -301 M | -288 M | -277 M | -264 M | -250 M | -236 M | - | -212 M | -197 M | -189 M | -176 M | -166 M | -153 M | -153 M | -153 M | -153 M | -109 M | -108 M | -108 M | -108 M | -71.8 M | -71.8 M | -71.8 M | -71.8 M | -32.8 M | -32.8 M | -32.8 M | -32.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
44.8 M | 42.3 M | 61.5 M | 68.9 M | 73.2 M | 81.7 M | 91.3 M | 76.3 M | - | 90.7 M | 83.4 M | 78.9 M | 89.7 M | 88.7 M | 99.5 M | 99.5 M | 99.5 M | 99.5 M | 71.6 M | 71.6 M | 71.6 M | 71.6 M | 45.4 M | 45.4 M | 45.4 M | 45.4 M | 67 M | 67 M | 67 M | 67 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
32.4 M | 30 M | 48.5 M | 54.7 M | 52.9 M | 56.3 M | 51.6 M | 29.7 M | - | 67.9 M | 64.4 M | 67.6 M | 73.9 M | 73.3 M | 74.9 M | 74.9 M | 74.9 M | 74.9 M | 44.3 M | 44.3 M | 44.3 M | 44.3 M | 20.8 M | 20.8 M | 20.8 M | 20.8 M | 63.5 M | 3.4 M | 63.5 M | 63.5 M | 14.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
25.4 M | 21.6 M | 37.1 M | 42.7 M | 46 M | 55 M | 65.7 M | 50.8 M | - | 64.7 M | 65.5 M | 63.5 M | 72.9 M | 69.7 M | 78.9 M | 78.9 M | 78.9 M | 78.9 M | 54.6 M | 54.6 M | 54.6 M | 54.6 M | 34 M | 34 M | 34 M | 34 M | 61.6 M | 61.6 M | 27.7 M | 61.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
25.4 M | 21.6 M | 37.1 M | 42.7 M | 46 M | 55 M | 65.7 M | 50.8 M | 59.8 M | 64.7 M | 65.5 M | 63.5 M | 72.9 M | 69.7 M | 78.9 M | 78.9 M | 78.9 M | 78.9 M | 54.6 M | 54.6 M | 54.6 M | 54.6 M | 34 M | 34 M | 34 M | 34 M | 61.6 M | 61.6 M | 61.6 M | 61.6 M | 15.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung